Keytruda was approved for locally advanced head and neck cancer before and after surgery, showing improved event-free ...

After digesting Cardinal Health's 2025 investor day, we inched up our 2026 revenue and EPS assumptions and lifted our stage II growth rates by 50 basis points to reflect a stronger distribution market ...

An oral tablet formulation of zanubrutinib was approved for use in patients with certain lymphomas or leukemia and ...

In 2022 alone, chemical abortions accounted for 63% of all abortions in the United States, totaling 642,700 . Shockingly, ...

The FDA approved intravesical mitomycin in non–muscle-invasive bladder cancer as an nonsurgical alternative to transurethral ...

After decades of antipsychotic drugs, a new FDA-approved treatment for schizophrenia targets a different brain system—with ...

Sunscreen is a skincare essential, but with so many options marketed for babies, kids and adults, it can be hard to know which one to pick, especially if you’re packing for a family day out. We asked ...

CMSC attendees were encouraged at Helius' recent successes in obtaining initial reimbursement from federal and private payers ...

Nor were they aware of research published on whether warning labels about additives specifically improved public health ...

Liquidia finally launched Yutrepia after years of legal battles, but faces entrenched competition from United Therapeutics' ...

Liver cleanse products are growing in popularity, despite little evidence showing benefit.“The idea of a liver cleanse is ...

June 11, 2025) - Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ('Thiogenesis' or the 'Company') a clinical-stage biotechnology company developing disulfides that drive the production of ...